research use only
Cat.No.S7256
| Related Targets | HDAC JAK BET Histone Methyltransferase PKC PARP HIF PRMT EZH2 AMPK |
|---|---|
| Other p300/CBP Inhibitors | Inobrodib (CCS-1477) A-485 Curcumin Anacardic Acid CPI-637 E7386 GNE-049 Histone Acetyltransferase Inhibitor II TTK21 I-CBP112 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| RKO | Function assay | 24 hrs | Inhibition of doxorubicin-stimulated p53 (unknown origin) expressed in human RKO cells preincubated for 24 hrs followed by addition of doxorubicin for 16 hrs by luciferase reporter assay, IC50 = 1.5 μM. | 26572217 | ||
| AMO1 | Function assay | 6 hrs | Inhibition of CBP/EP300 in human AMO1 cells assessed as reduction in MYC expression after 6 hrs by quantigene plex assay, EC50 = 2.7 μM. | 27190605 | ||
| HEK293 | Function assay | Inhibition of Halo-tagged histone H3.3 binding to NanoLuc luciferase conjugated CBP (unknown origin) expressed in HEK293 cells after overnight incubation by BRET assay, IC50 = 2.8 μM. | 27682507 | |||
| RKO | Function assay | 24 hrs | Inhibition of p53-induced (unknown origin) expressed in human RKO cells assessed as reduction in p53-induced p21 activation measured after 24 hrs by luciferase reporter gene assay, IC50 = 1.54 μM. | ChEMBL | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 100 mg/mL
(196.44 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 509.04 | Formula | C28H33ClN4O3 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1613695-14-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)CC(C)N5CCOCC5 | ||
| Features |
CREBBP/EP300-selective chemical probe.
|
|---|---|
| Targets/IC50/Ki |
CREBBP
(Cell-free assay) 21 nM
EP300
(Cell-free assay) 38 nM
|
| In vitro |
As a CREBBP/EP300-selective chemical probe, SGC-CBP30 shows moderate cytotoxicity in U2OS cells and HeLa cells. |
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | IKZF1 / IKZF3 / p-STAT3 / STAT3 / IRF4 / Myc |
|
30741931 |
| Growth inhibition assay | Cell viability |
|
30741931 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
The recommended formulation for in vivo studies on your website is “2% DMSO+30% PEG 300+5% Tween 80+ddH2O”. Is this a suspension or clear solution?
Answer:
It in 2% DMSO+30% PEG 300+5% Tween 80+ddH2O at 5mg/ml is a clear solution.